Tuberculosis treatment without rifampin in kidney/kidney–pancreas transplantation: A case series report

The best approach to tuberculosis (TB) treatment in transplanted patients is still unknown. Current guidelines are based on evidence either extrapolated from other populations or observational. Rifampin‐containing regimens have strong pharmacokinetic interactions with immunosuppressive regimens, with high rates of organ dysfunction and ∼20% mortality. This report describes the results obtained using non‐rifampin‐containing regimens to treat confirmed TB in adult patients with kidney/kidney–pancreas transplantation.